Articles & guides — page 3
92 cited, vendor-independent pieces on the questions people actually ask — reconstitution and handling, half-lives, compound comparisons, and how to track a protocol. Research and education only; never dosing advice, never sourcing.
92 articles
How long does semaglutide stay in your system?
How long semaglutide persists: with a ~7-day half-life, roughly five weeks to clear a single dose. The math, the accumulation caveat, and the cited sources.
Approved medicineHalf-life & pharmacology2 minHow long does tirzepatide stay in your system?
Tirzepatide persistence: a ~5-day half-life means roughly 25 days to clear a single dose, longer with accumulation. The math, the sources, and the caveats.
Approved medicineHalf-life & pharmacology2 minWhat happens if you miss a semaglutide dose?
The pharmacology of a missed weekly semaglutide dose: why the ~7-day half-life cushions a late dose, and how far levels fall over time. Not medical advice.
Approved medicineHalf-life & pharmacology2 minWhat happens if you miss a tirzepatide dose?
The kinetics of a missed weekly tirzepatide dose: how the ~5-day half-life shapes the decline in levels. Reference information, not medical advice.
Approved medicineHalf-life & pharmacology2 minWhy are GLP-1 medications dosed weekly?
The pharmacology behind weekly GLP-1 dosing: how a multi-day half-life, achieved by fatty-acid modification and albumin binding, makes once-weekly administration possible.
Approved medicineHalf-life & pharmacology2 minBPC-157 half-life: why effects outlast the serum level
BPC-157's short serum half-life versus its longer-lasting effects in research — the pharmacokinetic-pharmacodynamic disconnect, explained with the primary PK data.
PreclinicalHalf-life & pharmacology2 minWhat does peptide concentration mean?
Concentration in mg/mL explained: why it is the bridge between vial size and syringe units, and why the same dose can be many different unit counts.
Concept / methodHalf-life & pharmacology2 minSubQ vs IM injections explained
Subcutaneous versus intramuscular administration: the tissue layer each targets, how it changes the absorption curve, and why route appears in research protocols.
Concept / methodHalf-life & pharmacology2 minWhat are GLP-1 receptor agonists?
GLP-1 receptor agonists explained: what the incretin hormone GLP-1 does, what "agonist" means, and how modern versions are engineered to last for days.
Approved medicineHalf-life & pharmacology2 minWhat are growth hormone secretagogues?
Growth-hormone secretagogues explained: the two receptor families (GHRH analogs and ghrelin/GHS agonists), why they are paired, and where each compound fits.
Concept / methodCompound overviews6 minWhat is BPC-157?
BPC-157 explained with the primary literature: the pentadecapeptide’s structure, its proposed VEGFR2 angiogenic mechanism, and an honest look at an evidence base that is almost entirely preclinical.
PreclinicalCompound overviews4 minWhat is TB-500?
TB-500 explained with the literature: how this thymosin β4 fragment sequesters actin to drive cell migration, and the crucial catch — the human trials tested eye drops, not muscle injections.
PreclinicalZyra Labs is a research and educational utility. Nothing on this page is medical advice, a dosing recommendation, or an endorsement of any compound. We never sell or source compounds and refuse sourcing questions. Consult a qualified clinician for decisions about your health.